INVENT Pharmaceuticals
"transforming molecules to medicines"

INVENT Pharmaceuticals is developing novel and innovative small molecule drugs for the the treatment of serious diseases with high unmet medical need to help improve quality of life of people living with serious diseases.

INVENT Pharmaceuticals is  advancing the development of its  differentiated therapeutics for the treatment of  Cardiopulmonary, Cardiorenal diseases,  Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM), and hATTR Polyneuropathy (hATTR-PN) , Alzheimer's disease, Addiction/Substance Use Disorders (SUD/AUD), and Neuropsychiatric disorders, Attention Deficit Hyperactivity Disorders (ADHD), General Anxiety Disorder (GAD) and Major Depressive Disorder (MDD), Neuroendocrine Tumors and other diseases.

We are dedicated to help improve patients' lives by innovative drug discovery and developement of next generation of small molecule drugs (medicines).